Finally, we found that GARS promotes the bladder cancer progression in human urinary bladder carcinoma cell lines, T24 and 5637, through enhancing pentose phosphate pathway flux by inhibiting activities of PGK1 and PKM2. Here, PKM is linked to urinary bladder carcinoma.